Ilika plc (LON: IKA), an independent global expert in solid-state battery technology, has announced that it has appointed Cavendish Capital Markets Limited as Nominated Adviser and Sole Broker with immediate effect.
Ilika appoints Cavendish Capital Markets as Nominated Adviser and Sole Broker
- Written by: Amilia Stone
Find more news, interviews, share price & company profile here for:
Latest Company News
Ilika has completed its £3 million PRIMED programme, reporting improved energy density, charging, power, cycle life and thermal stability for its 10Ah Goliath solid-state battery cells, alongside new commercial opportunities in defence, e-bikes and other applications.
Ilika will present its UK-developed quasi-solid-state cell technology at The Faraday Institution’s Next Frontiers in Energy Storage event on Tuesday 8 September.
Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.
Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.
Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.
